Delivery Order SPE2DB20D1100-SPE2DB24FC7M7
Award Date
7/15/24
Potential Completion Date
8/5/24
Potential Value
$83K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $50,818.95, is for the supply of NovoSeven RT 5 mg vials, a specialty pharmaceutical product. The contract has an ultimate completion date of March 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,911.29 firm fixed-price contract is for the delivery of NovoSeven RT 5 mg vials, a specialty medication. The contract has an ultimate completion date of September 19, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NovoSeven RT 5 mg vials. The contract, valued at $6,911.29, is a firm fixed-price delivery order with an ultimate completion date of September 12, 2024. There is no set-aside designation for this award. Amerisourcebergen, through its Corporate Office division, will provide this critical medication to support various federal healthcare...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,760.43, is for the delivery of 4563398480 NOVOSeven RT 2 MG vials and has a completion date of February 12, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,846.64 firm fixed-price delivery order is for the supply of NovoSeven RT 2 mg vials, a specialty medication. This award is a part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,900.96 Firm Fixed Price delivery order contract is for the supply of NovoSeven RT 5 mg vials, a specialty medication. The contract has an ultimate completion date of December 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 2 mg vials of the medication NovoSeven RT, with a ceiling value of $2,760.43 and an ultimate completion date of December 2, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside designation, indicating open competition. AmerisourceBergen holds a large...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,750.80 firm fixed-price delivery order is for the supply of 4,566,658,071 units of the medication NovoSeven RT 5 mg vials. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,760.43, is for the delivery of NovoSeven RT 2 mg vials, a specialty medication used in the treatment of hemophilia. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of March 5, 2024. The award is not designated as a set-aside contract....
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,312,251 vials of the medication NovoSeven RT 2 mg. The $5,520.86 contract has a completion date of February 2, 2024. Amerisourcebergen Drug Corp, a for-profit organization, has previously provided pharmaceuticals and medical supplies to support DLA Troop Support Medical programs. This delivery order does not have a...